Tenaya Therapeutics’ (TNYA) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA – Free Report) in a research report ...
Spire Wealth Management Acquires New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA)
Spire Wealth Management bought a new position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) in the fourth quarter, ...
Investing5d
Tenaya Therapeutics appoints new interim principal accounting officer
In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa ...
Investing5d
Tenaya Therapeutics appoints new interim principal accounting officer
In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa, who has ...
Morningstar3d
Tenaya Therapeutics Inc TNYA
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
MarketWatch5d
Sionna Therapeutics Upsized IPO Priced at High End of Views
Shares of Sionna Therapeutics are set to be traded Friday ... it is selling nearly 10.6 million shares at $18 apiece in the IPO, compared with prior plans to offer about 8.82 million shares ...
Seeking Alpha2d
SpringWorks Therapeutics may be worth around $77 a share in a takeover - analyst
SpringWorks Therapeutics (NASDAQ:SWTX) may be valued at about $77 a share in a possible takeover after a report earlier that Merck KGaA (OTCPK:MKGAF) is in talks for a purchase of the cancer and ...